Generics - Antibiotics and Infectious diseases, India

Filter

Popular Filters

FTC puts conditions on Sun Pharma’s proposed acquisition of Ranbaxy

FTC puts conditions on Sun Pharma’s proposed acquisition of Ranbaxy

01-02-2015

Indian drugmakers Sun Pharmaceutical Industries Ltd. and Ranbaxy Laboratories have agreed to divest Ranbaxy’s…

Antibiotics and Infectious diseasesGenericsIndiaLegalMergers & AcquisitionsMinocyclineRanbaxy LaboratoriesSun Pharmaceutical IndustriesTorrent PharmaceuticalsUSA

Indian industry decries smear campaign against its pharma exporters

Indian industry decries smear campaign against its pharma exporters

26-09-2014

The India Brand Equity Foundation (IBEF), on behalf of the government of India, has taken strong objection…

Antibiotics and Infectious diseasesGenericsIndiaMarkets & MarketingPoliticsProductionUSA

Mylan pushes further into India, introducing critical care segment

Mylan pushes further into India, introducing critical care segment

12-03-2014

US generics major Mylan says its Indian subsidiary has launched a Critical Care segment in India. The…

AmbisomeAntibiotics and Infectious diseasesAsia-PacificGenericsIndiaMarkets & MarketingMylan Laboratories

COMPANY SPOTLIGHT

Menarini

Back to top